Q2 2026
· Form 13F Ledger
Data source: SEC EDGAR
DARK
H
HOLDER
.TOP
Who owns what — the quarterly ledger of U.S. institutional holdings.
EN
·
简
·
繁
Overview
Stocks
Funds
Most Bought
Most Sold
Latest Filings
Funds /
Regeneron Pharmaceuticals, Inc.
Form 13F · Q2 2026
Regeneron Pharmaceuticals, Inc.
CIK 872589
Filed 2026-08-07
13F-HR
View the filing on EDGAR ↗
$177M
Reported book value
3
Positions
7
Quarters on record
Top 50
Positions
Regeneron Pharmaceuticals, Inc. — holdings
Top 3 positions of 3, ranked by reported value. Share change is versus the previous quarter.
#
Security
Shares
Share Δ QoQ
Value
% of book
1
PBLS
Parabilis Medicines Inc
4.2M
—
$114M
64.4%
2
NTLA
Intellia Therapeutics Inc
3.7M
+0.0%
$63M
35.4%
3
ACET
Adicet Bio Inc
60,511
—
$522,819
0.3%
Source: Form 13F filings via SEC EDGAR. Positions as of Jun 30, 2026. Options (put/call) are excluded from share counts.